[Congressional Record Volume 163, Number 3 (Thursday, January 5, 2017)]
[Senate]
[Pages S118-S119]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 9. Ms. KLOBUCHAR (for herself, Mr. Franken, Mr. Blumenthal, Mr. 
Leahy, Mr. Udall, Mr. Durbin, Ms. Stabenow, Mr. Van Hollen, Mr. 
Whitehouse, Mr. King, Mr. Brown, Ms. Baldwin, and Mrs. Shaheen) 
submitted an amendment intended to be proposed

[[Page S119]]

by her to the concurrent resolution S. Con. Res. 3, setting forth the 
congressional budget for the United States Government for fiscal year 
2017 and setting forth the appropriate budgetary levels for fiscal 
years 2018 through 2026; which was ordered to lie on the table; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO THE 
                   REPEAL OF THE MEDICARE PART D NONINTERFERENCE 
                   CLAUSE.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution 
     for one or more bills, joint resolutions, amendments, 
     amendments between the Houses, motions, or conference reports 
     relating to the repeal of the noninterference clause under 
     the Medicare part D prescription drug program in order to 
     allow the Secretary of Health and Human Services to negotiate 
     for the best possible price for prescription drugs by the 
     amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over either the period of the total of fiscal years 2017 
     through 2021 or the period of the total of fiscal years 2017 
     through 2026.
                                 ______